Transparency in Clinical Trials: Developments and New Priorities

Pharmaceutical Promotion Peer Training Pilot

Strengthening and streamlining national law responses beyond COVID19: Trade and intellectual property rules in the context of access to health technologies

Access to Insulin 100 Years On: Premiere and Q&A

International Snakebite Awareness Day 2021

Transparency Matters: Using data to protect health

The Pandemic Preparedness Treaty: Unlocking intellectual property, knowledge and know-how for the public good

HAI 40th Anniversary Conference

No Business As Usual: Challenging the IP Protection Framework Now and After COVID-19

40 years of HAI: Launch of ACCISS study


Centenary of the Discovery of Insulin 2021

The Great Health Hack!

Gender Mainstreaming in Health Programs: Equality, Diversity and Inclusion

International Snakebite Awareness Day

Women Champions Leading the Fight Against Snakebite: A Global Dialogue Highlighting Snakebite Prevention, Treatment and Management Responses During COVID-19 and Beyond

How can we ensure public return on public investment?: Access to medicines in the context of COVID19

WHA Resolution on Access to Insulin

The WHO Covid-19 Technology Pool

Pharmaceutical Marketing: Taking Action

Nothing magical about medicine prices


Big Pharma: The new digital influencers?

Licensing Publicly Funded Knowledge: Seeking a Socially Sustainable Balance

Transparency and Clinical Trials in the EU

International Snakebite Awareness Day 2019

72nd World Health Assembly, Geneva

HAI Europe Association AGM